Answer
Iodixanol (Visipaque) is contraindicated in patients with hypersensitivity to iodixanol or any excipient, or manifest thyrotoxicosis.
Sources for this answer
- VISIPAQUE 320 mg I/ml Solution for Injection, glass container and polypropylene containerGE Healthcare Limited · emc · SmPC §4.3 Contraindications · Version 6Document updated
Sources checked